The relationships between molecular features and clinical drug responses lay the foundation for optimizing drug therapies based on a patient’s genomic context.
With the fast development and reduced costs of high throughput technologies, more efforts are made to identify genomic markers that can predict drug responses. As precision medicine takes into account the genomic variability of individuals in oncology practice, accurately predicting response to cancer drugs based on molecules becomes a critical issue.
Read the entire article in Oxford Academic’s Bioinformatics here.